Date: 2015-04-13
Type of information: Company acquisition
Acquired company: CAPP Medical (USA - CA)
Acquiring company: Roche (Switzerland)
Amount: undisclosed
Terms: * On April 13, 2015, Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood. Financial details were not disclosed.
Details: CAPP Medical is developing disruptive liquid non-invasive cancer detection technology using next generation DNA sequencing. CAPP Medical\'s novel technology is designed to isolate and quantify small amounts of ctDNA through a simple blood draw, which has the potential to be used for cancer therapy selection and monitoring tumor response and resistance to therapy.
Related: Cancer - Oncology Diagnostic
